AHL Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $4.78M | Buy |
45,604
+1,093
| +2% | +$114K | 0.07% | 501 |
|
|
2017
Q3 | $5.02M | Buy |
44,511
+17,907
| +67% | +$2.02M | 0.09% | 399 |
|
|
2017
Q2 | $2.98M | Buy |
26,604
+6,923
| +35% | +$776K | 0.06% | 522 |
|
|
2017
Q1 | $2.3M | Sell |
19,681
-889
| -4% | -$104K | 0.05% | 596 |
|
|
2016
Q4 | $2.17M | Buy |
20,570
+7,348
| +56% | +$774K | 0.07% | 487 |
|
|
2016
Q3 | $1.46M | Buy |
13,222
+6,389
| +94% | +$706K | 0.05% | 481 |
|
|
2016
Q2 | $995K | Buy |
6,833
+1,681
| +33% | +$245K | 0.05% | 446 |
|
|
2016
Q1 | $738K | Sell |
5,152
-13,641
| -73% | -$1.95M | 0.05% | 468 |
|
|
2015
Q4 | $2.9M | Buy |
18,793
+15,189
| +421% | +$2.35M | 0.22% | 156 |
|
|
2015
Q3 | $515K | Sell |
3,604
-32,233
| -90% | -$4.61M | 0.08% | 364 |
|
|
2015
Q2 | $5.15M | Sell |
35,837
-3,344
| -9% | -$480K | 0.21% | 167 |
|
|
2015
Q1 | $5.53M | Buy |
39,181
+20,401
| +109% | +$2.88M | 0.22% | 130 |
|
|
2014
Q4 | $2.78M | Buy |
+18,780
| New | +$2.78M | 0.14% | 276 |
|